Implantable Repository for Local Bioactive Agent Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for attaching bioactive agents to medical devices are complex and costly, limiting their application to only specific devices and not allowing for widespread local delivery to tissue sites during surgical procedures.

Innovation Solution

An implantable repository with a housing containing a bioactive agent and an attachment member, designed to be coupled to medical devices or tissue surfaces, allowing for secure deposition and attachment using wound closure devices such as fasteners or sutures, enabling broad tissue coverage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If bioactive agents are attached to medical devices using surface modification methods, then local delivery of bioactive agents is achieved, but the process becomes complicated and costly

Engineering Contradiction:
Improvelocal delivery of bioactive agentVSAvoidattachment process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system separates the bioactive agent delivery function from the medical device itself by using independent implantable repositories that can be attached to various devices. This segmentation allows the bioactive agent to be delivered locally without complicating the medical device manufacturing process, as the repository is a separate, standardized component.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The implantable repository acts as an intermediary carrier between the medical device and the bioactive agent. Instead of directly attaching the bioactive agent to the medical device through complex surface modification, the repository serves as a simple attachment platform that holds the bioactive agent and can be easily coupled to the medical device using standard attachment members.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If bioactive agents are coated on specific medical devices, then local delivery is achieved for those devices, but other devices at the tissue site cannot benefit from local delivery

Engineering Contradiction:
Improvelocal delivery of bioactive agentVSAvoidapplicability to different medical devices
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The implantable repository is designed as a universal platform that can be attached to multiple types of medical devices through standardized attachment members. This allows a single repository design to serve multiple functions across different surgical procedures and device types, enabling broad adaptability while maintaining reliable local delivery of bioactive agents.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If surface modification methods are used to attach bioactive agents, then bioactive agents can be applied as coating, but the process is costly

Engineering Contradiction:
Improvebioactive agent applicationVSAvoidmanufacturing cost
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The implantable repository is designed as a disposable, pre-loaded carrier that eliminates the need for expensive surface modification processes. The repository can be manufactured independently with the bioactive agent already incorporated, then attached to medical devices as a complete unit, significantly reducing manufacturing costs compared to custom surface modification of each medical device.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Data Source

PatentUS8900616B2System and method for satellite drug delivery
Publication Date: 2014.12.02 COVIDIEN LP
  • US8900616B2 patent drawing
  • US8900616B2 patent drawing
  • US8900616B2 patent drawing

AI summary

The present disclosure is directed to an implantable repository including a housing comprising at least one bioactive agent and at least one attachment member coupled to the housing, the at least one attachment member configured to couple the implantable repository to at least one of a medical device and a tissue surface.